Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

A systematic review of adherence to cardiovascular medications in resource-limited settings.

Bowry AD, Shrank WH, Lee JL, Stedman M, Choudhry NK.

J Gen Intern Med. 2011 Dec;26(12):1479-91. doi: 10.1007/s11606-011-1825-3. Epub 2011 Aug 20. Review.

2.

The importance of social ties in sustaining medication adherence in resource-limited settings.

Tsai AC, Bangsberg DR.

J Gen Intern Med. 2011 Dec;26(12):1391-3. doi: 10.1007/s11606-011-1841-3. No abstract available.

3.

Adherence to cardiovascular therapy: a meta-analysis of prevalence and clinical consequences.

Chowdhury R, Khan H, Heydon E, Shroufi A, Fahimi S, Moore C, Stricker B, Mendis S, Hofman A, Mant J, Franco OH.

Eur Heart J. 2013 Oct;34(38):2940-8. doi: 10.1093/eurheartj/eht295. Epub 2013 Aug 1. Review.

PMID:
23907142
4.

Cardiovascular medication utilization and adherence among adults living in rural and urban areas: a systematic review and meta-analysis.

Murphy GK, McAlister FA, Weir DL, Tjosvold L, Eurich DT.

BMC Public Health. 2014 Jun 2;14:544. doi: 10.1186/1471-2458-14-544.

5.

The burden of non-adherence to cardiovascular medications among the aging population in Australia: a meta-analysis.

McKenzie SJ, McLaughlin D, Clark J, Doi SA.

Drugs Aging. 2015 Mar;32(3):217-25. doi: 10.1007/s40266-015-0245-1. Review.

PMID:
25749743
6.

Medication adherence: a call for action.

Bosworth HB, Granger BB, Mendys P, Brindis R, Burkholder R, Czajkowski SM, Daniel JG, Ekman I, Ho M, Johnson M, Kimmel SE, Liu LZ, Musaus J, Shrank WH, Whalley Buono E, Weiss K, Granger CB.

Am Heart J. 2011 Sep;162(3):412-24. doi: 10.1016/j.ahj.2011.06.007. Review.

7.

Improving Adherence to Cardiovascular Therapies: An Economic Evaluation of a Randomized Pragmatic Trial.

Smith DH, O'Keeffe-Rosetti M, Owen-Smith AA, Rand C, Tom J, Vupputuri S, Laws R, Waterbury A, Hankerson-Dyson DD, Yonehara C, Williams A, Schneider J, Dickerson JF, Vollmer WM.

Value Health. 2016 Mar-Apr;19(2):176-84. doi: 10.1016/j.jval.2015.11.013. Epub 2016 Feb 12.

8.

Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries.

Wirtz VJ, Kaplan WA, Kwan GF, Laing RO.

Circulation. 2016 May 24;133(21):2076-85. doi: 10.1161/CIRCULATIONAHA.115.008722. Review.

9.

Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence.

Balu S, Simko RJ, Quimbo RM, Cziraky MJ.

Curr Med Res Opin. 2009 Nov;25(11):2765-75. doi: 10.1185/03007990903297741.

PMID:
19785511
10.

The cardiovascular polypill: clinical data and ongoing studies.

Castellano JM, Bueno H, Fuster V.

Int J Cardiol. 2015 Dec;201 Suppl 1:S8-14. doi: 10.1016/S0167-5273(15)31027-5. Review.

11.

Interventions to increase adherence to medications for tobacco dependence.

Hollands GJ, McDermott MS, Lindson-Hawley N, Vogt F, Farley A, Aveyard P.

Cochrane Database Syst Rev. 2015 Feb 23;(2):CD009164. doi: 10.1002/14651858.CD009164.pub2. Review.

PMID:
25914910
12.

Predictors of long-term adherence to evidence-based cardiovascular disease medications in outpatients with stable atherothrombotic disease: findings from the REACH Registry.

Rodriguez F, Cannon CP, Steg PG, Kumbhani DJ, Goto S, Smith SC, Eagle KA, Ohman EM, Umez-Eronini AA, Hoffman E, Bhatt DL; REACH Registry Investigators.

Clin Cardiol. 2013 Dec;36(12):721-7. doi: 10.1002/clc.22217. Epub 2013 Oct 25.

13.

Medication adherence self-report instruments: implications for practice and research.

Rolley JX, Davidson PM, Dennison CR, Ong A, Everett B, Salamonson Y.

J Cardiovasc Nurs. 2008 Nov-Dec;23(6):497-505. doi: 10.1097/01.JCN.0000338931.96834.16.

PMID:
18953213
14.

Interventions to improve safe and effective medicines use by consumers: an overview of systematic reviews.

Ryan R, Santesso N, Lowe D, Hill S, Grimshaw J, Prictor M, Kaufman C, Cowie G, Taylor M.

Cochrane Database Syst Rev. 2014 Apr 29;(4):CD007768. doi: 10.1002/14651858.CD007768.pub3. Review.

PMID:
24777444
15.

Physician effectiveness in interventions to improve cardiovascular medication adherence: a systematic review.

Cutrona SL, Choudhry NK, Stedman M, Servi A, Liberman JN, Brennan T, Fischer MA, Brookhart MA, Shrank WH.

J Gen Intern Med. 2010 Oct;25(10):1090-6. doi: 10.1007/s11606-010-1387-9. Epub 2010 May 13. Review.

16.

Targeting cardiovascular medication adherence interventions.

Cutrona SL, Choudhry NK, Fischer MA, Servi AD, Stedman M, Liberman JN, Brennan TA, Shrank WH.

J Am Pharm Assoc (2003). 2012 May-Jun;52(3):381-97. doi: 10.1331/JAPhA.2012.10211. Review.

PMID:
22618980
17.

Interventions to improve adherence to antiretroviral therapy in children with HIV infection.

Bain-Brickley D, Butler LM, Kennedy GE, Rutherford GW.

Cochrane Database Syst Rev. 2011 Dec 7;(12):CD009513. doi: 10.1002/14651858.CD009513. Review.

PMID:
22161452
18.

The association between multimorbidity and poor adherence with cardiovascular medications.

Wong MC, Liu J, Zhou S, Li S, Su X, Wang HH, Chung RY, Yip BH, Wong SY, Lau JT.

Int J Cardiol. 2014 Dec 15;177(2):477-82. doi: 10.1016/j.ijcard.2014.09.103. Epub 2014 Sep 28.

PMID:
25443249
19.

Adherence to cardiovascular medications: lessons learned and future directions.

Kronish IM, Ye S.

Prog Cardiovasc Dis. 2013 May-Jun;55(6):590-600. doi: 10.1016/j.pcad.2013.02.001. Epub 2013 Mar 23. Review.

20.

Drug treatment and cost of cardiovascular disease in Australia.

Ademi Z, Liew D, Chew D, Conner G, Shiel L, Nelson M, Soman A, Steg G, Bhatt DL, Reid C; REACH registry investigators.

Cardiovasc Ther. 2009 Fall;27(3):164-72. doi: 10.1111/j.1755-5922.2009.00090.x.

PMID:
19689615

Supplemental Content

Support Center